Fri, Apr 26, 2024 9:40 AM
Netlink Solutions India Q4 Results: profit rise by 62.15% YOY
A Flip by Shubhangi Gupta
Reported Consolidated quarterly numbers for Vivanza Biosciences are: Net Sales at Rs 4.42 crore in March 2024 down 46.32% from Rs. 8.24 crore in March 2023. Quarterly Net Loss at Rs. 0.41 crore in March 2024 down 299.52% from Rs. 0.10 crore in March 2023. EBITDA stands negative at Rs. 0.16 crore in March 2024 down 233.33% from Rs. 0.12 crore in March 2023.
Open Flip
Reported Consolidated quarterly numbers for Swastika Investsmart are: Net Sales at Rs 36.54 crore in March 2024 up 62.88% from Rs. 22.43 crore in March 2023. Quarterly Net Profit at Rs. 4.25 crore in March 2024 up 333.66% from Rs. 0.98 crore in March 2023. EBITDA stands at Rs. 8.77 crore in March 2024 up 221.25% from Rs. 2.73 crore in March 2023.
Open Flip
Emkay Global Financial's research report on Go Fashion. GO’s Q4 print was weak, albeit results were largely in line and outperformance (vs. peers) continued with 15% topline growth. SSG was low at +1%/0% in Q4/FY24 and GO is targeting 2-3% SSG for Q1. Given the muted macros, FY24 has been a year of WC optimization, as GO generated Rs 1.1 bn operating cash vs. cash-breakeven in FY23.
Open Flip
